Final quality of life (QOL) results with geographical analysis for sunitinib versus interferon-alfa, as first-line therapy in patients with metastatic renal cell carcinoma (MRCC) Meeting Abstract


Authors: Cella, D.; Michaelson, M. D.; Bushmakin, A. G.; Cappelleri, J. C.; Charbonneau, C.; Kim, S. T.; Li, J. Z.; Motzer, R. J.
Abstract Title: Final quality of life (QOL) results with geographical analysis for sunitinib versus interferon-alfa, as first-line therapy in patients with metastatic renal cell carcinoma (MRCC)
Meeting Title: International Society for Pharmacoeconomics and Outcomes Research 12th Annual European Congress
Journal Title: Value in Health
Volume: 12
Issue: 7
Meeting Dates: 2009 Oct 24-27
Meeting Location: Paris, France
ISSN: 1098-3015
Publisher: Elsevier Science, Inc.  
Date Published: 2009-10-01
Start Page: A283
Language: English
ACCESSION: ISI:000269878100314
PROVIDER: wos
DOI: 10.1016/S1098-3015(10)74389-8
Notes: --- - Meeting Abstract: PCN139 - "Source: Wos"
Altmetric
Citation Impact
MSK Authors
  1. Robert Motzer
    950 Motzer